Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc.verified

ONCT

Price:

$1.4481

Market Cap:

$4.29M

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen r...[Read more]

Industry

Biotechnology

IPO Date

2004-02-03

Stock Exchange

NASDAQ

Ticker

ONCT

The Dividend Yield as of September 2024 (TTM) for Oncternal Therapeutics, Inc. (ONCT) is 0%

According to Oncternal Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Oncternal Therapeutics, Inc. (ONCT) Historical Dividend Yield (quarterly & annually)

How has ONCT Dividend Yield performed in the past?

The mean historical Dividend Yield of Oncternal Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ONCT's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Oncternal Therapeutics, Inc. (ONCT) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Oncternal Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%

Oncternal Therapeutics, Inc. (ONCT) Average Dividend Yield

How has ONCT Dividend Yield performed in the past?

The current Dividend Yield of Oncternal Therapeutics, Inc. (ONCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Oncternal Therapeutics, Inc. (ONCT) Dividend Yield vs. Peers

How is ONCT’s Dividend Yield compared to its peers?

Oncternal Therapeutics, Inc.’s Dividend Yield is less than Neoleukin Therapeutics, Inc. (0%), less than CytomX Therapeutics, Inc. (0%), less than Assembly Biosciences, Inc. (0%), less than Instil Bio, Inc. (0%), less than Nuvation Bio Inc. (0%), less than Protara Therapeutics, Inc. (0%), less than Vaccinex, Inc. (0%), less than Monopar Therapeutics Inc. (0%), less than Miromatrix Medical Inc. (0%), less than Surrozen, Inc. (0%), less than Passage Bio, Inc. (0%), less than Absci Corporation (0%), less than Adverum Biotechnologies, Inc. (0%), less than Kezar Life Sciences, Inc. (0%), less than Armata Pharmaceuticals, Inc. (0%), less than Pasithea Therapeutics Corp. (0%), less than Aditxt, Inc. (0%), less than null (0%),

Build a custom stock screener for Oncternal Therapeutics, Inc. (ONCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncternal Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncternal Therapeutics, Inc. (ONCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncternal Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Oncternal Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Oncternal Therapeutics, Inc. (ONCT)?

What is the highest Dividend Yield for Oncternal Therapeutics, Inc. (ONCT)?

What is the 3-year average Dividend Yield for Oncternal Therapeutics, Inc. (ONCT)?

What is the 5-year average Dividend Yield for Oncternal Therapeutics, Inc. (ONCT)?

How does the current Dividend Yield for Oncternal Therapeutics, Inc. (ONCT) compare to its historical average?